We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+4.05%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$6.32B
AUM Growth
+$456M
Cap. Flow
+$224M
Cap. Flow %
3.55%
Top 10 Hldgs %
17.62%
Holding
844
New
72
Increased
349
Reduced
257
Closed
60

Top Buys

Rank Stock Value
1
AVGO icon
Broadcom
AVGO
+$37.6M
2
BMY icon
Bristol-Myers Squibb
BMY
+$29.3M
3
BIIB icon
Biogen
BIIB
+$27.4M
4
HD icon
Home Depot
HD
+$22.7M
5
CSCO icon
Cisco
CSCO
+$21.1M

Top Sells

Rank Stock Value
1
JPM icon
JPMorgan Chase
JPM
+$23.6M
2
TJX icon
TJX Companies
TJX
+$19.3M
3
FDX icon
FedEx
FDX
+$16.4M
4
INTU icon
Intuit
INTU
+$14.7M
5
GLW icon
Corning
GLW
+$13.3M

Sector Composition

Rank Sector Weight
1 Healthcare 25.18%
2 Technology 17.19%
3 Financials 12.85%
4 Consumer Discretionary 10.2%
5 Communication Services 8.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NFX
201
DELISTED
Newfield Exploration
NFX
$8.19M 0.13%
270,838
+177,452
+190% +$5.02M
BHVN
202
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$8.19M 0.13%
207,099
+102,099
+97% +$3.24M
CF icon
203
CF Industries
CF
$19.2B
$8.14M 0.13%
183,413
+120,985
+194% +$4.93M
WEX icon
204
WEX
WEX
$6.11B
$8.1M 0.13%
42,495
+24,298
+134% +$4.24M
EVHC
205
DELISTED
Envision Healthcare Holdings Inc
EVHC
$7.98M 0.13%
181,348
+87,133
+92% +$3.58M
IPGP icon
206
IPG Photonics
IPGP
$3.89B
$7.87M 0.12%
35,674
+17,861
+100% +$4.22M
NBIX icon
207
Neurocrine Biosciences
NBIX
$17.7B
$7.87M 0.12%
80,100
+15,100
+23% +$1.35M
SRPT icon
208
Sarepta Therapeutics
SRPT
$1.66B
$7.8M 0.12%
59,000
+11,000
+23% +$1.04M
SGEN
209
DELISTED
Seagen Inc. Common Stock
SGEN
$7.74M 0.12%
116,600
+4,600
+4% +$264K
CFG icon
210
Citizens Financial Group
CFG
$30.4B
$7.73M 0.12%
198,709
+79,896
+67% +$3.33M
AMT icon
211
American Tower
AMT
$77.7B
$7.58M 0.12%
52,600
+4,548
+9% +$632K
EOG icon
212
EOG Resources
EOG
$78B
$7.52M 0.12%
60,416
+504
+0.8% +$58.6K
TECH icon
213
Bio-Techne
TECH
$11.2B
$7.49M 0.12%
202,400
+26,400
+15% +$1.01M
AMBA icon
214
Ambarella
AMBA
$2.99B
$7.37M 0.12%
190,944
+29,229
+18% +$1.38M
RGA icon
215
Reinsurance Group of America
RGA
$15.7B
$7.37M 0.12%
55,196
-21,708
-28% -$3.24M
APC
216
DELISTED
Anadarko Petroleum
APC
$7.24M 0.11%
98,896
-22,083
-18% -$1.5M
MSI icon
217
Motorola Solutions
MSI
$69.4B
$7.23M 0.11%
62,160
+436
+0.7% +$48.1K
UHS icon
218
Universal Health Services
UHS
$9.43B
$7.23M 0.11%
64,904
+38,462
+145% +$4.51M
FOLD
219
DELISTED
Amicus Therapeutics
FOLD
$7.2M 0.11%
461,000
-4,000
-0.9% -$60.5K
EVRG icon
220
Evergy
EVRG
$20.1B
$7.2M 0.11%
+128,209
New +$6.87M
HAL icon
221
Halliburton
HAL
$27.9B
$7.14M 0.11%
158,458
-205,944
-57% -$10.3M
DHI icon
222
D.R. Horton
DHI
$41B
$7.13M 0.11%
173,882
+85,652
+97% +$3.7M
NRG icon
223
NRG Energy
NRG
$29.8B
$7.08M 0.11%
230,596
+164,660
+250% +$5.32M
EQT icon
224
EQT Corp
EQT
$33.2B
$7.08M 0.11%
235,654
-92,111
-28% -$2.57M
BALL icon
225
Ball Corp
BALL
$17B
$7.07M 0.11%
198,715
+150,333
+311% +$5.76M
7 8
9
10 11

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q2 2018 Portfolio in Review

As of Q2 2018, Candriam SCA held 844 positions worth $6.32B, up 7.8% from $5.86B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Candriam SCA deployed $224M of net new capital in Q2 2018, opening 72 new positions and adding to 349 existing holdings. Its largest new stake was Broadcom: 1,532,450 shares worth $37.2M.

By sector, the portfolio is most concentrated in Healthcare at 25% of assets, up from 23% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was JPMorgan Chase, an estimated $23.6M trimmed.

  • Candriam SCA's largest Q2 2018 buy was Broadcom: 1,532,450 shares worth $37.2M.
  • Candriam SCA added most to Bristol-Myers Squibb in Q2 2018, an estimated $29.3M increase.
  • Candriam SCA's biggest Q2 2018 reduction was JPMorgan Chase, cutting an estimated $23.6M.
  • Candriam SCA fully exited Monsanto Co in Q2 2018, selling an estimated $11.5M.
  • Candriam SCA's ten largest holdings make up 18% of its $6.32B portfolio in Q2 2018.
  • Candriam SCA opened 72 new positions and closed 60 in Q2 2018.
  • Candriam SCA's portfolio value rose 7.8% quarter-over-quarter to $6.32B.

Based on Candriam SCA's 13F filing for Q2 2018, filed 14 Aug 2018.